View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Infection News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 01, 2023
1 min read
Save

CDC warns against eating pre-cut cantaloupe amid growing Salmonella outbreak

CDC warns against eating pre-cut cantaloupe amid growing <i>Salmonella </i>outbreak

The CDC issued a warning Thursday not to eat pre-cut cantaloupe if the brand of the fruit is not known, the latest development in a growing outbreak of Salmonella infections that has sickened more than 100 people, killing two.

SPONSORED CONTENT
November 27, 2023
2 min read
Save

Chlorine no more effective than water at killing C. difficile, study finds

Chlorine no more effective than water at killing <i>C. diff</i><i>icile</i>, study finds

Chlorine-based bleach cleaning solutions are no more effective at killing Clostridioides difficile on surfaces and hospital scrubs than water, a study found.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
November 15, 2023
2 min read
Save

Norovirus doubles death risk for older veterans, study finds

Norovirus doubles death risk for older veterans, study finds

Older veterans were slightly more likely to be hospitalized and more than twice as likely to die in the 3 days after testing for norovirus compared with those who testing negative, according to study results.

SPONSORED CONTENT
November 15, 2023
2 min read
Save

Infection mitigation during pandemic may have benefited AH patients treated with steroids

Infection mitigation during pandemic may have benefited AH patients treated with steroids

BOSTON — Mortality rates were consistently lower in patients with severe alcohol-associated hepatitis treated with steroids during vs. before the COVID-19 pandemic, suggesting infection mitigation may have benefited this population.

SPONSORED CONTENT
November 07, 2023
25 min listen
Save

Highlights from ACG 2023

Highlights from ACG 2023

In this episode of Meeting Mic, we bring you Healio’s top headlines from ACG 2023.

SPONSORED CONTENT
November 04, 2023
2 min read
Save

Doxycycline lowers C. difficile risk in patients with pneumonia

Doxycycline lowers <i>C. diff</i><i>icile</i> risk in patients with pneumonia

Doxycycline reduced the risk for Clostridioides difficile infection by almost half compared with azithromycin among patients hospitalized with community-acquire pneumonia who had a C. difficile infection in the past year, a study found.

SPONSORED CONTENT
November 01, 2023
1 min watch
Save

VIDEO: Patients ‘might fall through the cracks’ between FMT, live microbiota therapies

VIDEO: Patients &lsquo;might fall through the cracks&rsquo; between FMT, live microbiota therapies

In a Healio video exclusive, Edward V. Loftus Jr., MD, highlighted benefits of newly available live biotherapeutics for Clostridioides difficile infection but noted concern for patients who don’t qualify and “might fall through the cracks.”

SPONSORED CONTENT
November 01, 2023
2 min watch
Save

VIDEO: Case report sheds light on ‘variances COVID-19 brings’ to UC treatment

VIDEO: Case report sheds light on &lsquo;variances COVID-19 brings&rsquo; to UC treatment

VANCOUVER, British Columbia — In this Healio video exclusive, Neslyne B. Augustin, MD, reviews the case of a patient with ulcerative colitis and concomitant SARS-CoV-2 infection, which she presented at the ACG Annual Scientific Meeting.

SPONSORED CONTENT
October 31, 2023
2 min read
Save

Patients with IBD at increased risk for respiratory syncytial virus infection

Patients with IBD at increased risk for respiratory syncytial virus infection

VANCOUVER, British Columbia — Adult patients with inflammatory bowel disease are at increased risk for respiratory syncytial virus infection and hospitalization, especially those with comorbidities, according to data presented here.

SPONSORED CONTENT
October 30, 2023
2 min read
Save

FDA approves reformulated Voquezna Triple, Dual Pak for H. pylori infection

FDA approves reformulated Voquezna Triple, Dual Pak for <i>H. pylori</i> infection

The FDA has approved the prior approval supplement for Phathom Pharmaceutical’s reformulated vonoprazan tablets for its Voquezna Triple Pak and Voquezna Dual Pak to treat adults with Helicobacter pylori infection, according to a company release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails